or
forgot password
  • cancer clinical trials in new london, CT

  • Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Oncology and Hematology Associates, PC
    New London, Connecticut 06320
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Lawrence and Memorial Hospital
    New London, Connecticut 06320
    Colorectal Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Lawrence and Memorial Hospital
    New London, Connecticut 06320
    Breast Cancer
    Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
    Coastal Connecticut Research, LLC
    New London, Connecticut 06320
    Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Test Facility
    New London, Connecticut 06320
    Hypoactive Sexual Desire Disorder
    Safety and Efficacy of LibiGelĀ® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 151
    New London, Connecticut 06320
    Hypoactive Sexual Desire Disorder
    Cognition in the Study of Tamoxifen and Raloxifene
    Lawrence & Memorial Hospital
    New London, Connecticut 06320
    Cognition, Aging